Inhibition of rat brain ecto-ATPase activity by various drugs

General Physiology and Biophysics

Volumn 25, Issue 1, 2006, Pages 91-105

  Horvat, Anica ^a   Orlic T ^a   Banjac, A ^a   Momic T ^a   Petrovic S ^a   Demajo, M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Drugs; Ecto ATPase; Rat; Synaptosomes

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANTIALLERGIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; DIGOXIN; PROMETHAZINE; PROPRANOLOL; PURINE P2 RECEPTOR; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; EPILEPSY; IC 50; IN VITRO STUDY; KINETICS; MALE; NEUROMODULATION; NONHUMAN; RAT; SYNAPTIC MEMBRANE;

EID: 33744495075     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Abbracchio M. (1997): ATP in brain function. In: Purinergic Approaches in Experimental Therapeutics (Eds. K. A. Jacobson and M. F. Jarvis), pp. 383-404, Wiley-Liss., Inc, New York, USA
2. Agarwal A., Tekwani B. L., Shukla O. P., Ghatak S. (1990): Effect of anthelminthics and phenothyazines on adenosine 5′-triphosphatases of filarial parasite Setaria cervi. Indian J. Exp. Biol. 28, 245-248
3. + current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil. Brain Res. 548, 41-49
4. Barcellos C. K., Schetinger M. R., Dias R. D., Sarkis J. J. (1998): In vitro effects of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats. Gen. Pharmacol. 31, 563-567
5. Biber K., Fiebich B. L., Gebicke-Harter P., van Calker D. (1999): Carbamazepine-induced upregulation of adenosine A1-receptors in astrocyte cultures affects coupling to the phosphoinositol signaling pathway. Neuropsychopharmacology 20, 271-278
6. Bruno A. N., Bonan C. D., Wofchuk S. T., Sarkis J. J., Battastini A. M. (2002): ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phases of development. Life Sci. 71, 215-225
7. Chelly J. E., Hill D. C., Abernethy D. R., Dlewati A., Doursout M. F., Merin R. G. (1987): Pharmacodynamic and pharmacokinetic interactions between lidocaine and verapamile. J. Pharmacol. Exp. Ther. 243, 211-216
8. Chen W., Wieraszko A., Hogan M. V., Yang H.-A., Komecki C., Ehrlich Y. H. (1996): Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. Proc. Natl. Acad. Sci. U.S.A. 93, 8688-8693
9. 2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia 28, 378-382
10. Cunha R. A. (2001): Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem. Int. 38, 107-125
11. Dixon M., Web E. C. (1987): Enzymes. Academic Press, New York
12. 2+ -ATPase activity in rat brain synaptosomes. Zhongguo Yao Li Xue Bao 15, 452-455 (in Chinese)
13. Fuhr U., Miller-Peltzer H., Kern R., Lorez-Rojas P., Junemann M., Harder S., Staib A. H. (2002): Effects of grapefruit juice and smoking on verapamil concentrations in steady state. Eur. J. Clin. Pharmacol. 58, 45-53
14. 2+ -ATPase activity of synaptosomal plasma membrane by the local anesthetics dibucaine and lidocaine. J. Neurochem. 54, 1238-1246
15. Gendron F. P., Benrezzak O., Krugh B. W., Kong Q., Weisman G. A., Beaudoin A. R. (2002): Purine signaling and potential new therapeutic approach: Possible outcomes of NTPDase inhibition. Curr. Drug Targets 3, 229-245
16. 2+ -ATPase. Chem. Biol. Interact. 103, 51-58
17. Gordon J. L. E1986): Extracellular ATP: effects, sources and fate. Biochem. J. 233, 309-319
18. Hawkins M., Pravica M., Radulovacki M. (1988): Chronic administration of diazepam downregulates adenosine receptors in the rat brain. Pharmacol. Biochem. Behav. 30, 303-308
19. Hehl E. M., Hennighausen G., Lange P. (1985): Ecto-ATPases in leukocytes and its modification by drugs. Allerg. Immunol. (Leipz.) 31, 17-23 (in German)
20. Hendrikse N. H., Schinkel A. H., de Vries E. G., Fluks E., Van der Graaf W. T., Willemsen A. T., Vaalburg W., Franssen E. J. (1998): Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. Br. J. Pharmacol. 124, 1413-1418
21. Horvat A., Nikezić G., Martinović J. (1995): Estradiol binding to synaptosomal plasma membranes of rat brains. Experientia 51, 11-15
22. Inoue K., Koizumi S., Ueno S. (1996): Implication of ATP receptors in brain functions. Prog. Neurobiol. 50, 483-492
23. Insel P. A., Ostrom R. S., Zambon A. C., Hughes R. J., Balboa M. A., Shehnaz D., Gregorian C., Torres B., Firestein B. L., Xing M., Post S. R. (2001): P2Y receptorE of MDCK cells: epithelial cell regulation by extracellular nucleotides. Clin. Exp. Pharmacol. Physiol. 28, 351-354
24. Kegel B., Braun N., Heine P., Maliszewski C. R., Zimmermann H. (1997): An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 36, 1189-1200
25. Knowles A. F., Nagy A. K. (1999): Inhibition of an ecto-ATP-diphosphohydrolase by azide. Eur. J. Biochem. 262, 349-357
26. Kukulski F., Komoszynski M. (2003): Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes. Eur. J. Biochem. 270, 3447-3454
27. Lichtman A. H., Segel G. B., Lichtman M. A. (1982): Effects of trifluoperazine and mitogenic lectins on calcium ATPase activity and calcium transport by human lymphocyte plasma membrane vesicles. J. Cell Physiol. 111, 213-217
28. Markwell M. A., Hass S. M., Bieber L. L, Tolbert N. E. (1978): A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210
29. Moriyama Y., Tsai H. L., Futai M. (1993): Energy-dependent accumulation of neuron blockers causes selective inhibition of neurotransmitter uptake by brain synaptic vesicles. Arch. Biochem. Biophys. 305, 278-281
30. 2+ -ATPase activity of the human erythrocyte membrane. Biochem. Mol. Biol. Int. 31, 823-832
31. Murakami A., Furui T. (1994): Effects of the conventional anticonvulsants, phenytoin, carbamazepine and valproic acid, on sodium-potassium-adenosine triphosphatase in acute ischemic brain. Neurosurgery 34, 1047-1051
32. Myers M. G., Lewis P. J., Reid J. L., Dollery C. T. (1975): Brain concentration of propranolol in relation to hypotensive effects in the rabbit with observations on brain propranolol levels in man. J. Pharmacol. Exp. Ther. 192, 327-335
33. Nagy A. (1986): Enzymatic characteristics and possible role of synaptosomal ecto-ATPases from mammalian brain. In: Cellular Biology of Ecto-Enzymes (Eds. G. W. Kreutzberg, M. Reddington and H. Zimmermann), pp. 49-59, Sringer-Verlag, Heidelberg-Berlin-New York-Tokyo
34. Nagy A. K. (1997): Ecto-ATPases of the nervous system. In: Ecto-ATPase Recent Progress on Sructure and Function (Eds. L. Plesner, T. L. Kirley and A. F. Knovles), pp. 1-13, Plenum Press, New York and London
35. Nagy A. K., Houser C. R., Delgado-Escueta A. V. (1990): Synaptosomal ATPase activities in temporal cortex and hippocampal formation of humans with focal epilepsy. Brain Res. 529, 192-201
36. Nagy A. K., Knowles A. F., Treiman L. J. (1999): Enzyme kinetical identification of E-type ATPase in brain tissues and in PC12 cells. In: Ecto-ATPases and Related Ectonucleotidases (Eds. L. Vanduffe and R. Lemmens), pp. 53-60, Shaker Publishing BV, Maastricht, The Nederland
37. Nedeljković N., Djordjević V., Horvat A., Nikezić G., Kanazir D. T. (2000): Effect of steroid hormone deprivation on the expression of ecto-ATPase in distinct brain region of female rats. Physiol. Res. 49, 419-426
38. Nedeljković N., Banjac A., Horvat A., Stojiljković M., Nikezić G. (2003): Ecto-ATPase and ecto-ATP-diphosphohydrolase are co-localized in rat hippocampal and caudate nucleus synaptic plasma membranes. Physiol. Res. 52, 797-804
39. Palatini P. (1982): Magnesium-dependent inhibition of beef heart soluble mitochondrial adenosine triphosphatase by tricyclic antipsychotics. Mol. Pharmacol. 21, 415-421
40. Pankratov Y., Castro E., Miras-Portugal M. T., Krishtal O. (1998): A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. Eur. J. Neurosci. 10, 3898-3902
41. Pennial R. (1966): An improved method for the determination of inorganic phosphate by the isobutanol-benzene extraction procedure. Anal. Biochem. 14, 87-90
42. Ragsdale D. S., Avoli M. (1998): Sodium channels as molecular target for antiepileptic drugs. Brain Res. Rev. 26, 16-28
43. + -ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenterology 74, 1183-1190
44. 2+ -ATPase activities of synaptosomes. Biochem. Pharmacol. 30, 1799-1803
45. Schetinger M. R., Porto N. M., Moretto M. B., Morsch V. M., da Rocha J. B, Vieira V., Moro F., Neis R. T., Bittencourt S., Bonacorso H. G., Zanatta N. (2000): New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochem. Res. 25(7), 949-955
46. Schneck D. W., Pritchard J. F., Hayes A. H. Jr. (1977): Studies on the uptake and binding of propranolol by rat tissues. J. Pharmacol. Exp. Ther. 203, 621-629
47. Srivastava M., Katyare S. S. (1983): The effect of propranolol on rat brain catecholamine biosynthesis. J. Biosci. 5, 261-266
48. Stout J. G., Kirley T. L. (1996): Control of cell membrane ecto-ATPase by oligomerization states: Intermolecular cross-linking modulates ATPase activity. Biochemistry 35, 8289-8298
49. Towle A. C., Sze P. Y. (1983): Steroid binding to synaptic plasma membrane: Differential binding of glucocorticoid and gonadal steroids. J. Steroid Biochem. 18, 135-143
50. Varga E., Szollosi J., Antal K., Kovacs P., Szabo J. Z. (1999): Nonspecific membrane effects of CH-103:hYdrophobicity, surface activity and membrane fluidity studies in comparation with propranolol and practolol. Pharmazie 54, 380-384
51. 2+ -ATPase in rat brain synaptosomes by EDTA. Toxicol. Lett. 110, 95-104
52. + -ATPase in mouse brain synaptosomes. J. Neurochem. 52, 1042-1049
53. Zalewska-Kaszubska J. (2002): Neuroprotective mechanisms of adenosine action on CNS neurons. Neurol. Neurochir. Pol. 36, 329-336 (in Polish)
54. Zimmermann H. (1994): Signaling via ATP in the nervous system. Trends Neurosci. 17, 420-426
55. Zimmermann H. (1996): Extracellular purine metabolism. Drug Dev. Res. 39, 337-352
56. Zimmermann H., Braun N., Kegel B., Heine P. (1998): New insights into molecular structure and function of ecto-nucleotidases in the nervous system. Neurochem. Int. 32, 421-425
57. Zinchuk V. S., Okada T., Kobayashi T. (1999): Ecto-ATPase activity in the rat cardiac muscle: Biochemical characteristics and histocytochemical localization. Cell Tissue Res. 298, 499-509